Literature DB >> 3861876

Interferon prevents the generation of spontaneous deletions at the left terminus of vaccinia virus DNA.

E Paez, M Esteban.   

Abstract

In this report we have shown that Friend erythroleukemia cells persistently infected with vaccinia virus maintain the persistent infection even after 1 year of continuous interferon (IFN) treatment. The persistently infected cultures were responsive to IFN as determined by their ability to induce 2-5A synthetase, to increase the intracellular levels of 2-5A, and to cause rRNA cleavage. While large deletions at the left terminus of vaccinia DNA occurred readily in the virus population from untreated cells, IFN completely suppressed the generation of these spontaneous deletions. Removal of IFN from these cultures led to the appearance of similar deletions at the left terminus of the viral genome. The regions deleted contain more than half of the left-end inverted terminal repetition of the vaccinia genome. These findings show that IFN alters specific events associated with the generation of vaccinia DNA deletions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3861876      PMCID: PMC252474     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Interferon inhibits transformation of mouse cells by exogenous cellular or viral genes.

Authors:  M F Dubois; M Vignal; M Le Cunff; C Chany
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

2.  The ppp(A2'p)nA and protein kinase systems in wild-type and interferon-resistant Daudi cells.

Authors:  R H Silverman; D Watling; F R Balkwill; J Trowsdale; I M Kerr
Journal:  Eur J Biochem       Date:  1982-08

3.  Inhibition of cell proliferation by interferons. 2. Changes in processing and stability of newly synthesized DNA in human lymphoblastoid (Daudi) cells.

Authors:  G Moore; D R Gewert; M J Clemens
Journal:  Eur J Biochem       Date:  1984-03-15

4.  2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication.

Authors:  A P Rice; W K Roberts; I M Kerr
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

5.  Persistent infection of Friend erythroleukemia cells with vaccinia virus.

Authors:  B G Pogo; C Friend
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

6.  Defective vaccinia virus particles in interferon-treated infected cells.

Authors:  M Esteban
Journal:  Virology       Date:  1984-02       Impact factor: 3.616

7.  Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus.

Authors:  T Takeya; H Hanafusa
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

8.  Interferon-mediated, double-stranded RNA-dependent protein kinase is inhibited in extracts from vaccinia virus-infected cells.

Authors:  A P Rice; I M Kerr
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

9.  Vaccinia rescue of VSV from interferon-induced resistance: reversal of translation block and inhibition of protein kinase activity.

Authors:  P Whitaker-Dowling; J S Youngner
Journal:  Virology       Date:  1983-11       Impact factor: 3.616

10.  A unique set of polypeptides is induced by gamma interferon in addition to those induced in common with alpha and beta interferons.

Authors:  J Weil; C J Epstein; L B Epstein; J J Sedmak; J L Sabran; S E Grossberg
Journal:  Nature       Date:  1983-02-03       Impact factor: 49.962

View more
  4 in total

1.  Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence.

Authors:  E Paez; S Dallo; M Esteban
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

2.  A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers.

Authors:  J F Rodriguez; E Paez; M Esteban
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

3.  Vaccinia Virus C9 Ankyrin Repeat/F-Box Protein Is a Newly Identified Antagonist of the Type I Interferon-Induced Antiviral State.

Authors:  Ruikang Liu; Bernard Moss
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

4.  Interferon cures cells lytically and persistently infected with African swine fever virus in vitro.

Authors:  E Paez; F Garcia; C Gil Fernandez
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.